Global Prostate Cancer Medicine Market Size, Status and Forecast 2021-2027

Global Prostate Cancer Medicine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 LHRH Antagonists
1.2.3 LHRH Analogs
1.2.4 Antiandrogens
1.2.5 Pipeline Drugs for Hormonal Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Medicine Market Perspective (2016-2027)
2.2 Prostate Cancer Medicine Growth Trends by Regions
2.2.1 Prostate Cancer Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Medicine Industry Dynamic
2.3.1 Prostate Cancer Medicine Market Trends
2.3.2 Prostate Cancer Medicine Market Drivers
2.3.3 Prostate Cancer Medicine Market Challenges
2.3.4 Prostate Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Medicine Players by Revenue
3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
3.4 Global Prostate Cancer Medicine Market Concentration Ratio
3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2020
3.5 Prostate Cancer Medicine Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Medicine Product Solution and Service
3.7 Date of Enter into Prostate Cancer Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Medicine Breakdown Data by Type
4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2022-2027)
5 Prostate Cancer Medicine Breakdown Data by Application
5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Prostate Cancer Medicine Market Size (2016-2027)
6.2 North America Prostate Cancer Medicine Market Size by Type
6.2.1 North America Prostate Cancer Medicine Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Medicine Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Medicine Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Medicine Market Size by Application
6.3.1 North America Prostate Cancer Medicine Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Medicine Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Medicine Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Medicine Market Size by Country
6.4.1 North America Prostate Cancer Medicine Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Prostate Cancer Medicine Market Size (2016-2027)
7.2 Europe Prostate Cancer Medicine Market Size by Type
7.2.1 Europe Prostate Cancer Medicine Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Medicine Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Medicine Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Medicine Market Size by Application
7.3.1 Europe Prostate Cancer Medicine Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Medicine Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Medicine Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Medicine Market Size by Country
7.4.1 Europe Prostate Cancer Medicine Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Medicine Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Medicine Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Medicine Market Size (2016-2027)
9.2 Latin America Prostate Cancer Medicine Market Size by Type
9.2.1 Latin America Prostate Cancer Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Medicine Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Medicine Market Size by Application
9.3.1 Latin America Prostate Cancer Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Medicine Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Medicine Market Size by Country
9.4.1 Latin America Prostate Cancer Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Medicine Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Medicine Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Details
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2016-2021)
11.1.5 AstraZeneca plc Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Details
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Prostate Cancer Medicine Introduction
11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2016-2021)
11.2.5 Active Biotech Recent Development
11.3 Bristol Myers-Squibb
11.3.1 Bristol Myers-Squibb Company Details
11.3.2 Bristol Myers-Squibb Business Overview
11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2016-2021)
11.3.5 Bristol Myers-Squibb Recent Development
11.4 Teva Pharmaceuticals Industries Ltd.
11.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2016-2021)
11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2016-2021)
11.6.5 Pfizer Inc. Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Prostate Cancer Medicine Introduction
11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2016-2021)
11.7.5 Bayer AG Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Astellas Pharma Inc.
11.9.1 Astellas Pharma Inc. Company Details
11.9.2 Astellas Pharma Inc. Business Overview
11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2016-2021)
11.9.5 Astellas Pharma Inc. Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2016-2021)
11.10.5 Roche Holding AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of LHRH Antagonists
Table 3. Key Players of LHRH Analogs
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Pipeline Drugs for Hormonal Therapy
Table 6. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prostate Cancer Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prostate Cancer Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Prostate Cancer Medicine Market Share by Regions (2016-2021)
Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Prostate Cancer Medicine Market Share by Regions (2022-2027)
Table 12. Prostate Cancer Medicine Market Trends
Table 13. Prostate Cancer Medicine Market Drivers
Table 14. Prostate Cancer Medicine Market Challenges
Table 15. Prostate Cancer Medicine Market Restraints
Table 16. Global Prostate Cancer Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Prostate Cancer Medicine Market Share by Players (2016-2021)
Table 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2020)
Table 19. Ranking of Global Top Prostate Cancer Medicine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Medicine Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Prostate Cancer Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Prostate Cancer Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Prostate Cancer Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca plc Company Details
Table 64. AstraZeneca plc Business Overview
Table 65. AstraZeneca plc Prostate Cancer Medicine Product
Table 66. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca plc Recent Development
Table 68. Active Biotech Company Details
Table 69. Active Biotech Business Overview
Table 70. Active Biotech Prostate Cancer Medicine Product
Table 71. Active Biotech Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 72. Active Biotech Recent Development
Table 73. Bristol Myers-Squibb Company Details
Table 74. Bristol Myers-Squibb Business Overview
Table 75. Bristol Myers-Squibb Prostate Cancer Medicine Product
Table 76. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 77. Bristol Myers-Squibb Recent Development
Table 78. Teva Pharmaceuticals Industries Ltd. Company Details
Table 79. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 80. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product
Table 81. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 82. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Prostate Cancer Medicine Product
Table 86. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Pfizer Inc. Company Details
Table 89. Pfizer Inc. Business Overview
Table 90. Pfizer Inc. Prostate Cancer Medicine Product
Table 91. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 92. Pfizer Inc. Recent Development
Table 93. Bayer AG Company Details
Table 94. Bayer AG Business Overview
Table 95. Bayer AG Prostate Cancer Medicine Product
Table 96. Bayer AG Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 97. Bayer AG Recent Development
Table 98. Abbott Laboratories Company Details
Table 99. Abbott Laboratories Business Overview
Table 100. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 101. Abbott Laboratories Recent Development
Table 102. Astellas Pharma Inc. Company Details
Table 103. Astellas Pharma Inc. Business Overview
Table 104. Astellas Pharma Inc. Prostate Cancer Medicine Product
Table 105. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 106. Astellas Pharma Inc. Recent Development
Table 107. Roche Holding AG Company Details
Table 108. Roche Holding AG Business Overview
Table 109. Roche Holding AG Prostate Cancer Medicine Product
Table 110. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2016-2021) & (US$ Million)
Table 111. Roche Holding AG Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Medicine Market Share by Type: 2020 VS 2027
Figure 2. LHRH Antagonists Features
Figure 3. LHRH Analogs Features
Figure 4. Antiandrogens Features
Figure 5. Pipeline Drugs for Hormonal Therapy Features
Figure 6. Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Other Case Studies
Figure 9. Prostate Cancer Medicine Report Years Considered
Figure 10. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Prostate Cancer Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostate Cancer Medicine Market Share by Regions: 2020 VS 2027
Figure 13. Global Prostate Cancer Medicine Market Share by Regions (2022-2027)
Figure 14. Global Prostate Cancer Medicine Market Share by Players in 2020
Figure 15. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Medicine as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2020
Figure 17. Global Prostate Cancer Medicine Revenue Market Share by Type (2016-2021)
Figure 18. Global Prostate Cancer Medicine Revenue Market Share by Type (2022-2027)
Figure 19. North America Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 21. North America Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 22. North America Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 23. United States Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 27. Europe Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 28. Europe Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 29. Germany Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Prostate Cancer Medicine Market Share by Region (2016-2027)
Figure 39. China Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 47. Latin America Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 48. Latin America Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 49. Mexico Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Cancer Medicine Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Prostate Cancer Medicine Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Prostate Cancer Medicine Market Share by Country (2016-2027)
Figure 55. Turkey Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Prostate Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 59. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 60. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 61. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 63. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 66. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 67. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs